Last reviewed · How we verify
NCT04332172: e-Health
Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy
NA trial testing General information in Fetal Alcohol Spectrum Disorders in 384 participants. Completed in 31 August 2025.
6 August 2025
Quick facts
| Lead sponsor | Michigan State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 384 |
| Start date | 19 May 2023 |
| Primary completion | 6 August 2025 |
| Estimated completion | 31 August 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- General information
- Baseline brief intervention
- Remote online booster sessions
- SMS
Conditions studied
- Fetal Alcohol Spectrum Disorders — all drugs for Fetal Alcohol Spectrum Disorders →
- Fetal Alcohol Syndrome — all drugs for Fetal Alcohol Syndrome →
- Fetal Alcohol Effect — all drugs for Fetal Alcohol Effect →
Sponsor
Michigan State University
Who can join
Adults 18 to 35, female only, with Fetal Alcohol Spectrum Disorders or Fetal Alcohol Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research study is to find out if pregnant women screening positive for alcohol risk like the brief alcohol intervention application that the investigators have developed (called the MommyCheckup, which is a technology-delivered SBIRT, or e-SBIRT), and if it helps them to reduce alcohol use. The investigators also wish to test whether e-SBIRT effects can be enhanced by booster sessions and/or tailored text messages.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Online randomised factorial trial of electronic Screening and Brief Intervention for alcohol use in pregnancy: a study protocol.
Ondersma SJ, Todd L, Jablonski S, Ahuja C, et al · · 2022 · cited 2× · PMID 35922101 · DOI 10.1136/bmjopen-2022-062735 -
Decentralized_eSBI_factorial_trial_alcohol_pregnancy_7_12_2022
Ondersma SJ, Todd L, Jablonski S, Ahuja C, et al · · 2022 · DOI 10.31234/osf.io/paqx9
Verify or expand the search:
- PubMed search for NCT04332172
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of General information
Trials testing the same drug.
- NCT06833736 — A Health App Using Recipes and Education Components to Facilitate Sustainable and Healthier Diets. · NA · completed
Other recruiting trials for Fetal Alcohol Spectrum Disorders
Currently open trials in the same condition.
- NCT06847165 — Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure · NA · recruiting
- NCT06638463 — My Health Coach App RCT · NA · recruiting
- NCT05960461 — Families Moving Forward (FMF) Connect Pro for Mental Health Providers · NA · recruiting
- NCT04395196 — RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure · Phase 2 · recruiting
- NCT05534568 — The Oklahoma Parent-Child Assistance Program · NA · recruiting
Other Michigan State University trials
Trials by the same sponsor.
- NCT06325150 — The Impact of Light Exposure on Cognitive Function in Classrooms · Phase 1 · not yet recruiting
- NCT07213284 — Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial · NA · not yet recruiting
- NCT07164391 — Empowering Vietnamese Americans · NA · not yet recruiting
- NCT04521972 — Impact of Room Light on Uterine Contractions and Labor Progression in Pregnancy · NA · recruiting
- NCT05358964 — Family Health Histories: Creating a Culturally Tailored Tool to Reduce Health Disparities in the Black Community · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04332172 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Michigan State University
- Last refreshed: 24 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04332172.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing